Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Vigna

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Idcases|January 31, 2022
Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccinationCarlo Bova, Ernesto Vigna, Massimo Gentile
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2025
Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic CriteriaEnrica Antonia Martino, Giuseppe Mele, Ernesto Vigna, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Expert Opinion on Biological Therapy|May 17, 2024
Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literatureEmiliano Barbieri, Enrica Antonia Martino, Elena Rivolti, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2007
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patientMassimo Gentile, Eugenio Lucia, Caterina Iorio, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Idcases|January 31, 2022
Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccinationCarlo Bova, Ernesto Vigna, Massimo Gentile
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2025
Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic CriteriaEnrica Antonia Martino, Giuseppe Mele, Ernesto Vigna, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Biological Therapy|May 23, 2013
Perspectives in the treatment of multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Expert Opinion on Investigational Drugs|July 4, 2015
Ixazomib for the treatment of multiple myelomaMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Expert Opinion on Biological Therapy|May 17, 2024
Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literatureEmiliano Barbieri, Enrica Antonia Martino, Elena Rivolti, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2007
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patientMassimo Gentile, Eugenio Lucia, Caterina Iorio, et al.
Pageof 12